-
Mashup Score: 6ARVO 2025: Stromal keratitis in the ZED study - 6 hour(s) ago
Christina Prescott, MD, talks about the rate of recurrence of stromal keratitis in the Zoster Eye Disease Study, both in the placebo and in the treatment group.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 9Q&A: Christine Kay, MD, gives an investigator's perspective on the PRISM clinical trial - 14 hour(s) ago
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
At the 2025 Association for Research in Vision and Ophthalmology (ARVO) annual meeting, Christine Kay, MD, of Vitreoretinal Associates in Gainesville, Florida, shared an update from the PRISM clinical trial. https://t.co/UE0g9XWdee
-
-
Mashup Score: 3
NCX 470, Nicox’s lead clinical product candidate, is a novel NO-donating bimatoprost eye drop with a dual mechanism of action (nitric oxide and prostaglandin analogue).
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Nicox has announced the results of its Whistler phase 3b exploratory clinical trial investigating the intraocular pressure (IOP)-lowering effects of NCX 470 ophthalmic solution, 0.1%, in healthy volunteers and ocular hypertensive patients. https://t.co/omTNjSB7MS
-
-
Mashup Score: 4
Ellen Koo, MD, presented data from first in-human clinical trials, looking at the results from magnetic cell therapy and reports on the efficacy and safety in the patients.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
At ARVO, Ellen Koo, MD, presented data from first in-human clinical trials, looking at the results from magnetic cell therapy and reports on the efficacy and safety in the patients. Watch: https://t.co/FT9xRjrZ2G
-
-
Mashup Score: 9OCTA role in retinal microvascular changes in SLE patients - 2 day(s) ago
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
A new study reported the importance of OCTA for detecting the early changes in the retinal vascular plexus in patients with systemic lupus erythematosus (SLE), especially those with lupus nephritis, even before the development of retinopathy https://t.co/sw5Gb9LtSc
-
-
Mashup Score: 3EyeCool Therapeutics announces results from pilot study of novel chronic ocular surface pain treatment - 2 day(s) ago
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Clinical-stage medical technology company EyeCool Therapeutics, Inc., announced positive results from a pilot study focused on its investigational device, ETX-4143. The device is intended for the treatment of chronic ocular surface pain (COSP). https://t.co/QsegyIOm2z
-
-
Mashup Score: 5Structure-function link between ellipsoid zone integrity features and visual acuity in eyes with GA - 2 day(s) ago
A recent analysis reveals a strong link between photoreceptor health and visual function in geographic atrophy, emphasizing the importance of EZ integrity.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
A post hoc analysis of the data from the GATHER1 and GATHER2 studies showed a clear structure-function link in geographic atrophy (GA) between the health of the photoreceptors measured and visual function https://t.co/qqy0MdDaVi
-
-
Mashup Score: 5
Palatin Technologies reveals groundbreaking preclinical results on melanocortin agonists, showcasing their potential to combat diabetic retinopathy and preserve vision.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Palatin Technologies recently announced preclinical data on the company’s melanocortin agonists PL9654 and PL9655 – both agents were found to have efficacy across multiple models and routes of administration, including topical delivery. https://t.co/XUKTr6GaCa
-
-
Mashup Score: 9
Ophthalmology Times – ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
Get insights on the latest advances in retinal therapy: -PDS surgery -Clinical outcomes -Faricimab + aflibercept 8mg Hear the latest from Aleksandra Rachitskaya, MD, and Jordan Graff, MD, FACS. Watch the series: https://t.co/hnMlDyRKza #IntravitrealTherapy #PortDeliverySystem https://t.co/i200s68v3B
-
-
Mashup Score: 7
A recent study reveals how geographic atrophy affects patients’ vision and quality of life, highlighting their coping strategies and need for better resources.
Source: www.ophthalmologytimes.comCategories: General Medicine News, OphthalmologyTweet-
A new study found that patients with GA had various vision-related symptoms that impact their health-related quality of life and independence causing them to develop significant coping mechanisms to live with the disease. https://t.co/w0Tk3K3LOa
-
At ARVO, Christina Prescott, MD, talked about the rate of recurrence of stromal keratitis in the Zoster Eye Disease Study, both in the placebo and in the treatment group. https://t.co/uDCVhN45K6